Bisphosphonates' antitumor activity: An unravelled side of a multifaceted drug class : Skeletal Complications of CancerCLEZARDIN, Philippe.Bone (New York, NY). 2011, Vol 48, Num 1, pp 71-79, issn 8756-3282, 9 p.Article

Activité anti-tumorale des bisphosphonates : mythe ou réalité ? = Anti-tumor effects of bisphosphonates: myth or reality?CLEZARDIN, Philippe.Revue du rhumatisme (Ed. française). 2002, Vol 69, Num 10-11, pp 997-1001, issn 1169-8330, 5 p.Conference Paper

Rôle de la triade RANK/RANKL/ostéoprotégérine (OPG) dans les cancers primitifs et secondaires de l'os: aspects physiopathologiques et implications cliniques = The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implicationsCLEZARDIN, Philippe.Bulletin du cancer. 2011, Vol 98, Num 7, pp 837-846, issn 0007-4551, 10 p.Article

Physiopathologie des métastases osseuses et nouvelles cibles moléculaires impliquées dans le remodelage osseux = Pathophysiology of bone metastases and new molecular targets involved in bone remodellingCLEZARDIN, Philippe.Bulletin du cancer. 2013, Vol 100, Num 11, pp 1083-1091, issn 0007-4551, 9 p.Article

Pathogénie des métastases osseuses = Pathophysiology of bone metastasesCLEZARDIN, Philippe.Revue du rhumatisme (Ed. française). 2008, Vol 75, Num 4, pp 327-331, issn 1169-8330, 5 p.Article

Bisphosphonates et métastases osseuses des tumeurs solides: intérêt thérapeutique au-delà de l'activité anti-ostéolytique = Biphosphonates in bone metastasesCLEZARDIN, Philippe.Progrès en urologie (Paris). 2003, Vol 13, Num 2, pp 28-35, issn 1166-7087, 8 p.Article

The antitumor potential of bisphosphonatesCLEZARDIN, Philippe.Seminars in oncology. 2002, Vol 29, Num 6, pp 33-42, issn 0093-7754, 10 p., SUP21Conference Paper

In vitro and in vivo antitumor effects of BisphosphonatesCLEZARDIN, Philippe; FOURNIER, Pierrick; BOISSIER, Sandrine et al.Current medicinal chemistry. 2003, Vol 10, Num 2, pp 173-180, issn 0929-8673, 8 p.Article

Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasisGREEN, Jonathan R; CLEZARDIN, Philippe.American journal of clinical oncology. 2002, Vol 25, Num 6, pp S3-S9, issn 0277-3732, SUP1Article

Effects of Bone-Targeted Agents on Cancer Progression and MortalityCOLEMAN, Robert; GNANT, Michael; MORGAN, Gareth et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 14, pp 1059-1067, issn 0027-8874, 9 p.Article

Bisphosphonates and cancer-induced bone disease : Beyond their antiresorptive activityCLEZARDIN, Philippe; EBETINO, Frank H; FOURNIER, Pierrick G. J et al.Cancer research (Baltimore). 2005, Vol 65, Num 12, pp 4971-4974, issn 0008-5472, 4 p.Article

Acide lysophosphatidique : un nouveau lien entre plaquettes sanguines et métastases osseuses = Lysophosphatidic acid : a new link between blood platelets and bone metastasisPEYRUCHAUD, Olivier; BOUCHARABA, Ahmed; SAULNIER-BLACHE, Jean-Sébastien et al.MS. Médecine sciences. 2005, Vol 21, Num 4, pp 353-355, issn 0767-0974, 3 p.Article

In Vivo Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Trigger Vγ9Vδ2 T-cell Antitumor Cytotoxicity through ICAM-1 EngagementBENZAÏD, Ismahène; MÖNKKÖNEN, Hannu; BONNELYE, Edith et al.Clinical cancer research (Print). 2012, Vol 18, Num 22, pp 6249-6259, issn 1078-0432, 11 p.Article

Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasisDAUBINE, Florence; LE GALL, Céline; GASSER, Juerg et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 4, pp 322-330, issn 0027-8874, 9 p.Article

Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesisDAVID, Marion; RIBEIRO, Johnny; DESCOTES, Françoise et al.International journal of oncology. 2012, Vol 40, Num 4, pp 1133-1141, issn 1019-6439, 9 p.Article

Bisphosphonates in preclinical bone oncologyCLEZARDIN, Philippe; BENZAÏD, Ismahène; CROUCHER, Peter I et al.Bone (New York, NY). 2011, Vol 49, Num 1, pp 66-70, issn 8756-3282, 5 p.Article

Increased expression and serum levels of the stromal cell- secreted protein periostin in breast cancer bone metastasesCONTIE, Sylvain; VOORZANGER-ROUSSELOT, Nathalie; LITVIN, Judith et al.International journal of cancer (Print). 2011, Vol 128, Num 2, pp 352-360, issn 0020-7136, 9 p.Article

Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancerBUIJS, Jeroen T; HENRIQUEZ, Nico V; LIDEREAU, Rosette et al.Cancer research (Baltimore). 2007, Vol 67, Num 18, pp 8742-8751, issn 0008-5472, 10 p.Article

A cathepsin K inhibitor reduces breast cancer-induced osteolysis and skeletal tumor burdenLE GALL, Céline; BELLAHCENE, Akeila; BONNELYE, Edith et al.Cancer research (Baltimore). 2007, Vol 67, Num 20, pp 9894-9902, issn 0008-5472, 9 p.Article

Early detection of bone metastases in a murine model using fluorescent human breast cancer cells : Application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesionsPEYRUCHAUD, Olivier; WINDING, Bent; PECHEUR, Isabelle et al.Journal of bone and mineral research (Print). 2001, Vol 16, Num 11, pp 2027-2034, issn 0884-0431Article

International society of geriatric oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patientsBODY, Jean-Jacques; COLEMAN, Rob; CLEZARDIN, Philippe et al.European journal of cancer (1990). 2007, Vol 43, Num 5, pp 852-858, issn 0959-8049, 7 p.Article

Rôle de l'angiogenèse tumorale dans le processus métastatique osseux? : OstéoporosePEYRUCHAUD, Olivier; SERRE, Claire-Marie; NICAMHLAOIBH, Roisin et al.Revue médicale de la Suisse romande. 2004, Vol 124, Num 2, pp 83-84, issn 0035-3655, 2 p.Article

Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated ratsFOURNIER, Pierrick; BOISSIER, Sandrine; FILLEUR, Stéphanie et al.Cancer research (Baltimore). 2002, Vol 62, Num 22, pp 6538-6544, issn 0008-5472, 7 p.Article

Dual Function of ERRα in Breast Cancer and Bone Metastasis Formation: Implication of VEGF and OsteoprotegerinFRADET, Anaïs; SOREL, Helène; CLEZARDIN, Philippe et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 17, pp 5728-5738, issn 0008-5472, 11 p.Article

High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote Vγ9Vδ2 T-Cell Chemotaxis and Cytotoxicity In VivoBENZAID, Ismahène; MÖNKKÖNEN, Hannu; STRESING, Verena et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 13, pp 4562-4572, issn 0008-5472, 11 p.Article